CTRI/2023/08/056433尚未招募4 期
A Prospective Randomized, Placebo-Controlled, Phase IV Study to Evaluate the Efficacy of CelWel in Patients with Postviral Fatigue Syndrome - NI
Carmel Research Consultancy Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male and female subjects over 18 years of age
- •2.Willingness to follow the protocol requirements
- •as evidenced by written, informed consent.
- •3.Mentally, physically and legally eligible to
- •give informed consent
- •4.Willingness to complete study questionnaires.
- •5.Able to use a smartphone and an mobile
- •application for delivering feedback every week
- •on symptoms
排除标准
- •1.Patients with pre-existing or other severe
- •systemic diseases that necessitate long-term
- •medication.
- •2.Any vascular or systemic disorder which could
- •affect any of the efficacy assessments.
- •3.Subjects received other medication (anti-viral)
- •within 36 hours before entry into the study.
- •4.Evidence of significant uncontrolled co-morbid
- •disease, which in the investigators opinion, would
- •jeopardize patient participation.
- •5.Patients hospitalized or requiring oxygen support
研究者
相似试验
进行中（未招募）
1 期
OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)EUCTR2018-000075-33-GBOmeros Corporation450
进行中（未招募）
1 期
OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)EUCTR2018-000075-33-SKOmeros Corporation450
进行中（未招募）
1 期
Benralizumab tested in patients with chronic prurigo.EUCTR2021-002818-13-DECharité-Universitätsmedizin Berlin48
进行中（未招募）
1 期
A study of androgen deprivation therapy (ADT) plus apalutamide (with or without abiraterone acetate with prednisone/prednisolone [AAP]) in patients with prostate cancerHigh-risk localized or locally advanced prostate cancerMedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-001746-34-FRJanssen-Cilag International NV1,500
进行中（未招募）
1 期
A study to see the Safety and Efficacy of Abaloparatide- SC for the Treatment of Men with OsteoporosisEUCTR2017-004220-30-ITRADIUS HEALTH, INC225